Clinical Trials on Carbohydrate Oxidation and Glycogen Utilization During and Following Exercise
Total 232 results
-
Maastricht University Medical CenterUnknownCarbohydrate Oxidation and Glycogen Utilization During and Following ExerciseNetherlands
-
Javier Gonzalez, PhDMaastricht University; University of Newcastle Upon-Tyne; Sugar Nutrition, UKCompletedLiver and Muscle Glycogen Use During Exercise.United Kingdom
-
Northumbria UniversityNewcastle University; Maastricht University; Sugar NutritionCompletedLiver and Muscle Glycogen Replenishment Post-exerciseUnited Kingdom
-
Northumbria UniversityBayerCompletedAffect and Exertion During and Post-exerciseUnited Kingdom
-
Duke UniversityKriya TherapeuticsRecruitingGlycogen Storage Disease VI | GLYCOGEN STORAGE DISEASE IXa1 | GLYCOGEN STORAGE DISEASE IXa2 | Glycogen Storage Disease IXB | Glycogen Storage Disease IXC | GSD 9 (All Subtypes) | GSD 6United States
-
Duzce UniversityRecruitingNursing Caries | Health Care UtilizationTurkey
-
University Hospitals Cleveland Medical CenterMelissa March; Alison Bauer; Gaetan Pettigrew; Daisy Hassani; Celina CunananWithdrawnEffect of Carbohydrate Ingestion During Active Labor
-
University Medical Center GroningenUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands
-
Turku University HospitalRecruiting
-
Ultragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands, United States
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
Sanguine BiosciencesTerminatedGlycogen Storage Disease Type IBUnited States
-
John MitchellCompletedGlycogen Storage Disease Type III | Glycogen Storage Disease Type IA | Glycogen Storage Disease Type IB | Glycogen Storage Disease Type 0Canada
-
Ultragenyx Pharmaceutical IncActive, not recruitingGlycogen Storage Disease Type IAUnited States, Brazil, Canada, Denmark, Germany, Italy, Netherlands, Spain
-
University of ManitobaCo-Investigator - Dr. Cheryl Rockman-GreenbergCompletedHypoglycemia | Glycogen Storage Disorder Type 1 | Cornstarch | GlycosadeCanada
-
Baylor Research InstituteUltragenyx Pharmaceutical IncCompletedAdult Polyglucosan Body Disease | Glycogen Brancher Enzyme Deficiency | Glycogen Storage Disease Type IVFrance
-
University Medical Center GoettingenWithdrawnUtilization of Nursing, Medical and Therapeutical Care of People Living at Home With Care Needs
-
Nicoline LøkkenCompleted
-
Ultragenyx Pharmaceutical IncActive, not recruitingGlycogen Storage Disease Type IA | Von Gierke's Disease (GSD Type Ia)Netherlands, United States, Canada, Spain
-
University Medical Center GroningenUniversity of Oxford; University of the Faroe Islands; Stichting Stofwisselkracht and other collaboratorsCompleted
-
Hospital de Clinicas de Porto AlegreConselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação Médica...CompletedGlycogen Storage Disease Type IBrazil
-
Rigshospitalet, DenmarkCompleted
-
Areeg El-GharbawyUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IUnited States
-
Institut National de la Santé Et de la Recherche...Rigshospitalet, DenmarkUnknownGlycogen Storage Disease Type V
-
Rigshospitalet, DenmarkUniversity College, LondonCompletedMcArdle DiseaseDenmark, United Kingdom
-
Reneo Pharma LtdCompletedMcArdle DiseaseSpain, United Kingdom
-
IRCCS Eugenio MedeaUniversity of Pisa; University of MessinaCompleted
-
Rigshospitalet, DenmarkCompleted
-
Rigshospitalet, DenmarkCompleted
-
Rigshospitalet, DenmarkCompletedGlycogen Storage Disease Type IIIDenmark
-
University of ZurichCompletedGlycogen Storage Disease Type 1 (GSD 1)Switzerland
-
University of British ColumbiaNatural Sciences and Engineering Research Council, CanadaRecruitingOzone Exposure During Rest and ExerciseCanada
-
Appalachian State UniversityDole Food CompanyCompletedExercise-induced Inflammation | Exercise-induced Oxidative Stress | Exercise-induced Immune DysfunctionUnited States
-
Ultragenyx Pharmaceutical IncTerminatedGlycogen Storage Disease Type IIIUnited States, Spain, Italy
-
ModernaTX, Inc.RecruitingGlycogen Storage DiseaseUnited States, Canada
-
Orpha LabsUnknownGlycogen Storage Disease, Type 14Turkey
-
Institut de Myologie, FranceUnknownNeuromuscular DisordersFrance
-
Ultragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IIIUnited States
-
Rigshospitalet, DenmarkUniversity of Texas Southwestern Medical Center; Groupe Hospitalier Pitie-Salpetriere and other collaboratorsCompletedGlycogen Storage Disease Type VDenmark
-
University College, LondonCompleted
-
Hong Kong Children's HospitalRecruitingGlycogen Storage Disease Type IBHong Kong
-
Duke UniversityRecruitingAdult Polyglucosan Body Disease | Glycogen Storage Disease Type IV | GSD4 | GSD IV | APBDUnited States
-
Ultragenyx Pharmaceutical IncTerminatedGlycogen Storage Disease Type IIIUnited States, Netherlands
-
Vitaflo International, LtdUniversity College London Hospitals; University Medical Center Groningen; University... and other collaboratorsCompletedGlycogen Storage DiseaseUnited States, United Kingdom, France, Netherlands
-
University of GlasgowKappa BioscienceCompletedInflammation | Exercise | Recovery | Oxidative Stress | Strength | Vitamin KUnited Kingdom
-
University of FloridaCompleted
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
CENTOGENE GmbH RostockWithdrawnFructose Metabolism, Inborn Errors | Glycogen Storage Disease Type II | Glycogen Storage Disease | Glycogen Storage Disease Type V | Glycogen Storage Disease Type I | Glycogen Storage Disease Type III | Glycogen Storage Disease Type VII | Glycogen Storage Disease Type IV | Glycogen Storage Disease Type... and other conditionsGermany, India, Sri Lanka
-
University of FloridaPrometheus LaboratoriesCompletedInflammatory Bowel Disease | Glycogen Storage Disease Type IaUnited States
-
Duke UniversityCompleted